Inaktiver Wert

Andere Sprachen Peptonic Medical AB Nasdaq Stockholm

Aktien

Schlusskurs Nasdaq Stockholm Andere Börsenplätze
- ^SEK	-

31.05.	Peptonic Medical AB erteilt Patent in Europa zur Linderung von provozierter Vulvodynie bei Frauen, Produkt bereit zur Markteinführung	CI
21.05.	Peptonic Medical AB kündigt organisatorische Änderungen an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Peptonic Medical AB Grants Patent in Europe for Relief of Provoked Vulvodynia in Women, Product Ready for Launch	31.05.
Peptonic Medical AB Announces Organizational Changes	21.05.
PEPTONIC medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.
Peptonic Medical AB Strengthens Its Position in Europe Through an Exclusive Distribution Agreement for Vagivital and Vernivia in the Benelux Region	02.04.
Farmasiet Extends Partnership with Peptonic Medical, Bringing VagVital's Product Portfolio to Norway	17.01.
Peptonic Medical AB Announces Patented Apoteket Offering in 293 Apoteket Stores	18.12.
PEPTONIC medical AB completed the acquisition of Pharmiva AB (OM : PHARM).	21.11.
Peptonic Medical Gains on Deal with Al Fotune for VagiVital VS Pro Distribution in UAE	13.11.
Peptonic Medical AB Signs Distribution Agreement with Al Fotune for United Arab Emirate	13.11.
Peptonic Medical AB's Self-Test for Bacterial Vivinosis to Be Sold in over 220 Apoteket Stores	08.11.
PEPTONIC medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	24.10.23
Peptonic Medical Lands First Vaginal Self-test Order for Central American Market	19.10.23
Peptonic Medical AB Receives First Order in Central America from Windsor Pharmaceuticals	19.10.23
PEPTONIC medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11.08.23
Peptonic Signs License Agreement with Prima Lab Regarding Menopause Test	11.07.23
Peptonic Medical AB Announces the Application to Patent Its Intimate Cleaner in US to Be Approved on June 20, 2023	13.06.23
Peptonic Signs License Agreement with Prima Lab Regarding Self-Test for Urinary Tract Infections	10.05.23
PEPTONIC medical AB Signs Distribution Agreement with Cetro Medical AB in Sweden	05.05.23
PEPTONIC medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	24.04.23
Peptonic Medical Signs Global Agreement with Siemens Healthineers	20.04.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Peptonic Medical AB Nasdaq Stockholm

Aktien

Andere Sprachen

Filter